0000000000122546

AUTHOR

Abass Alavi

showing 6 related works from this author

Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repagl…

2004

The 11 C-labeled sulfonylurea receptor 1 (SUR1) ligand (S)-2-(( 11 C)methoxy)-4-(3-methyl-1-(2-piperidine-1-yl-phenyl)- butyl-carbamoyl)-benzoic acid (( 11 C)methoxy-repaglinide) was synthesized in an overall radiochemical yield of 35% after 55 min with a radiochemical purity higher than 99%. This compound is considered for the noninvasive investigation of the SUR1 receptor status of pancreatic b-cells by positron emission tomography (PET) in the context of type 1 and type 2 diabetes. The specific activity was 40-70 GBq/lmol. In vitro testing of the nonradioactive methoxy-repaglinide was performed to characterize the affinity for binding to the human SUR1 isoform. Methoxy-repaglinide induce…

medicine.medical_specialtyPotassium Channelsmedicine.medical_treatmentReceptors DrugClinical BiochemistryPharmaceutical ScienceType 2 diabetesIn Vitro TechniquesSulfonylurea ReceptorsBiochemistryBenzoatesBinding CompetitiveIslets of LangerhansPiperidinesDiabetes mellitusInternal medicineDrug DiscoveryInsulin SecretionmedicineAnimalsHumansInsulinCarbon RadioisotopesPotassium Channels Inwardly RectifyingMolecular BiologyIC50Type 1 diabetesChemistryInsulinOrganic ChemistryStereoisomerismmedicine.diseaseRepaglinideLigand (biochemistry)RatsEndocrinologyPositron-Emission TomographyCOS CellsMolecular MedicineSulfonylurea receptorATP-Binding Cassette TransportersCarbamatesRadiopharmaceuticalsHydroxybenzoate Ethersmedicine.drugBioorganicmedicinal chemistry letters
researchProduct

Emerging Standards and the Hybrid Model for Organizing Scientific Events During and After The COVID-19 Pandemic

2020

AbstractSince the beginning of 2020, the coronavirus disease (COVID-19) pandemic has dramatically influenced almost every aspect of human life. Activities requiring human gatherings have either been postponed, canceled, or held completely virtually. To supplement lack of in-person contact, people have increasingly turned to virtual settings online, advantages of which include increased inclusivity and accessibility and a reduced carbon footprint. However, emerging online technologies cannot fully replace in-person scientific events. In-person meetings are not susceptible to poor Internet connectivity problems, and they provide novel opportunities for socialization, creating new collaboratio…

business.product_categorySanitationCoronavirus disease 2019 (COVID-19)event1117 Public Health and Health ServicesConcepts in Disaster Medicine03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingPandemicInternet accessHumans030212 general & internal medicineResilience (network)resiliencePandemicsEventPandemicResilienceEvent (computing)business.industryStrategic Defence & Security StudiesSARS-CoV-2pandemicSocializationPublic Health Environmental and Occupational HealthCongressCOVID-19standardPublic relationsStandardcongressCarbon footprintBusinessDelivery of Health Care030217 neurology & neurosurgery
researchProduct

Radiosynthesis of 1-(4-(2-[18F]fluoroethoxy)benzenesulfonyl)-3-butyl urea: a potentialβ-cell imaging agent

2002

Summary Tolbutamide (1) is a sulfonurea agent used to stimulate insulin secretion in type 2 diabetic patients. Its analogue 1-(4-(2-[ 18 F]fluoroethoxy)benzenesulfonyl)-3butyl urea (3) was synthesized in overall radiochemical yields of 45% as a potential b-cell imaging agent. Compound 3 was synthesized by 18 F-fluoroalkylation of the corresponding hydroxy precursor (2 )w ith 2-[ 18 F]fluoroethyltosylate in DMF at 1208C for 10 min followed by purification with HPLC in a synthesis time of 50 min. Insulin secretion experiments of the authentic 19 F-standard compound on rat islets showed that the compound has a similar stimulating effect on insulin secretion as that of tolbutamide (1). The part…

OctanolInsulinmedicine.medical_treatmentOrganic ChemistryRadiosynthesisBiochemistryMedicinal chemistryHigh-performance liquid chromatographyChemical synthesisAnalytical ChemistryPartition coefficientchemistry.chemical_compoundTolbutamideBiochemistrychemistryDrug DiscoverymedicineUreaRadiology Nuclear Medicine and imagingSpectroscopymedicine.drugJournal of Labelled Compounds and Radiopharmaceuticals
researchProduct

Synthesis and in vitro Evaluation of (S)-2-([11C]Methoxy)-4- [3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic Acid ([11C]Methoxy-repag…

2005

CellGeneral MedicineRepaglinideMedicinal chemistryIn vitroImaging agentchemistry.chemical_compoundmedicine.anatomical_structureBiochemistrychemistrymedicinePiperidineBenzoic acidmedicine.drugChemInform
researchProduct

Synthesis of fluorine-18 labeled sulfonureas as ?-cell imaging agents

2001

Tolbutamide (1) and glyburide (7) are hypoglycemic drugs used to stimulate insulin secretion in type 2 diabetic patients. We have synthesized their fluorine-18 labeled analogs, 1-[(4-[ 18 F]fluorobenzenesulfonyl)]-3-butyl]urea (p-[ 18 F]fluorotolbutamide, 3a) and N-{4-[β-(2-[ 18 F]fluoroethoxybenzene carboxamido)ethyl]benzenesulfonyl)-N'-cyclohexylurea (2-[ 18 F]fluoroethoxyglyburide, 6a) as β-cell imaging agents. Compound 3a was synthesized via two approaches: One-step synthesis via nucleophilic substitution of p-nitrotolbutamide (2) with K[ 18 F]/Kryptofix 2.2.2 in either CH 3 CN or DMSO gave a complicated mixture; a two-step synthesis via preparation and reaction of 4-[ 18 F]fluorobenzen…

medicine.drug_classStereochemistryOrganic ChemistryCarboxamideAlkylationBiochemistryChemical synthesisMedicinal chemistryHigh-performance liquid chromatographyAnalytical Chemistrychemistry.chemical_compoundTolbutamidechemistryYield (chemistry)Drug DiscoverymedicineUreaNucleophilic substitutionRadiology Nuclear Medicine and imagingSpectroscopymedicine.drugJournal of Labelled Compounds and Radiopharmaceuticals
researchProduct

Synthesis and evaluation of fluorine-18 labeled glyburide analogs as β-cell imaging agents

2003

Glyburide is a prescribed hypoglycemic drug for the treatment of type 2 diabetic patients. We have synthesized two of its analogs, namely N-[4-[beta-(2-(2'-fluoroethoxy)-5-chlorobenzenecarboxamido)ethyl]benzenesulfonyl]-N'-cyclohexylurea (2-fluoroethoxyglyburide, 8b) and N-[4-[beta-(2-(2'-fluoroethoxy)-5-iodobenzenecarboxamido)ethyl]benzenesulfonyl]-N'-cyclohexylurea (2-fluoroethoxy-5-deschloro-5-iodoglyburide, 8a), and their fluorine-18 labeled analogs as beta-cell imaging agents. Both F-18 labeled compound 8a and compound 8b were synthesized by alkylation of the corresponding multistep synthesized hydroxy precursor 4a and 4b with 2-[(18)F]fluoroethyl tosylate in DMSO at 120 degrees C for …

OctanolFluorine RadioisotopesCancer ResearchBiodistributionMice SCIDAlkylationHigh-performance liquid chromatographyMedicinal chemistryStreptozocinCell LineDiabetes Mellitus ExperimentalIslets of LangerhansMicechemistry.chemical_compoundIn vivoGlyburidemedicineAnimalsTissue DistributionRadiology Nuclear Medicine and imagingRadionuclide ImagingCells CulturedChemistrySmall intestineRatsPartition coefficientmedicine.anatomical_structureBiochemistryOrgan SpecificityIsotope LabelingMolecular MedicineSulfonylurea receptorRadiopharmaceuticalsNuclear Medicine and Biology
researchProduct